$58 Million
Joint Bookrunner
Initial Public Offering
February 2012
$63 Million
Joint Bookrunner
Initial Public Offering
January 2012
$50 Million
Joint Bookrunner
Follow-On
January 2012
$24 Million
Sole Bookrunner
Follow-On
January 2012
$90 Million
Sole Bookrunner
Follow-On
December 2011
$37 Million
Sole Financial Advisor
Series D Financing
November 2011
$60 Million
Joint Bookrunner
Follow-On
September 2011
$82 Million
Joint Bookrunner
Follow-On
July 2011
$52 Million
Joint Bookrunner
Follow-On
July 2011
$75M + $200M Earnout
Financial Advisor
Sale to Allergan
July 2011
$65 Million
Joint Bookrunner
Follow-On
June 2011
$518 Million
Co-Manager
Initial Public Offering
June 2011